TrialX
Image

Use of PCR-Sars-CoV-2 in Children

Use of PCR-Sars-CoV-2 in Children

Recruiting
14 years and younger
All
Phase N/A

Overview

In order to clarify the current management of young sick children in France, whether or not they are cared for in community settings (nursery, schools), paediatricians have proposed an algorithm whose objective is to help define the indications for PCR-Sars-CoV-2 (https://www.infovac.fr/actualites/bulletin-special-mai-2020).

This algorithm, in two parts, can be used, when symptoms are detected in children, to orient and guide :

  • first, parents and community personnel to recognize the signs of infection call signs that should involve medical consultation;
  • but also, the physicians who will carry out this medical evaluation and will have to decide whether or not PCR screening is necessary, in parallel with their diagnostic and therapeutic management, which should not be altered in this particular context

Our main objective is to describe, after the confinement phase, the management of young sick children in the community (crches, nursery and elementary schools, etc.) or not in order to best define the indications for PCR-Sars-CoV-2

Eligibility

Inclusion Criteria:

  • Children under 15 years of age
  • Prescription of a PCR-Sars-CoV-2
  • VIGIL information note given to parents

Exclusion Criteria:

  • Refusal to participate by the patient, family member or legal representative (depending on the situation)

Study details
    Covid 19

NCT04412317

Centre Hospitalier Intercommunal Creteil

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.